AI Article Synopsis

  • The article investigates how multiparametric magnetic resonance imaging (mpMRI) can improve prostate cancer diagnosis before conducting standard tru-cut biopsies in patients.
  • In a study involving 160 patients, mpMRI guided the biopsy process, showing significant differences in prostate-specific antigen levels between cancer and benign cases.
  • Results indicated that mpMRI results and biopsy findings were in complete agreement for identifying cancer zones, with the likelihood of adenocarcinoma significantly rising alongside increased mpMRI risk scores.

Article Abstract

Objective: This article aims to evaluate the efficacy of multiparametric magnetic resonance imaging before standard tru-cut biopsy in making prostate cancer diagnosis.

Materials And Methods: A total of 160 patients with prostate biopsy indications were prospectively evaluated between May 2017 and October 2018. Multiparametric magnetic resonance imaging was taken after obtaining a written informed consent from all patients. Cognitive transrectal ultrasound-guided biopsy was performed based on multiparametric magnetic resonance imaging results. Standard tru-cut biopsy was included to reduce false-negative rate. Statistical analysis was performed using the Statistical Package for Social Sciences version 20.0 software.

Results: The mean age of the patients was 65.94 ± 7.90 (48-84) years. Around 19.37% of the patients had a specificity in the digital rectal exam. The mean prostate-specific antigen value of the patients with adenocarcinoma was 42.1 ng/mL and it was 10.2 ng/mL in patients with benign prostate hyperplasia. It was observed that the prostate-specific antigen values in prostatic adenocarcinomas were significantly higher than those in benign prostate hyperplasia (P < .001). The results of multiparametric magnetic resonance imaging and the biopsy were 100% similar in terms of zones in patients with adenocarcinoma. All of the biopsy results of the patients who were evaluated to have normal prostate tissue in multiparametric magnetic resonance imaging were evaluated as benign prostate hyperplasia; on the other hand, 13.6% of PI-RADS 2 lesions, 14% of PI-RADS 3 lesions, 31.8% of PI-RADS 4 lesions, and 85.7% of PI-RADS 5 lesions were determined to be adenocarcinoma. It was observed that the prevalence of adenocarcinoma increased as the risk elevated in multiparametric magnetic resonance imaging (P < .001).

Conclusion: Multiparametric magnetic resonance imaging evaluated by experienced radiologists may be instructive of urologists and reduce the need for unnecessary biopsies.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634877PMC
http://dx.doi.org/10.5152/eurasianjmed.2022.20349DOI Listing

Publication Analysis

Top Keywords

multiparametric magnetic
32
magnetic resonance
32
resonance imaging
32
pi-rads lesions
16
prostate biopsy
12
benign prostate
12
prostate hyperplasia
12
patients
9
biopsy
8
multiparametric
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!